As expected, TAB182 silencing significantly lowered the protein level of β-catenin in the nucleus of ESCC cells, while over-expression of TAB182 elevated the nucleus distribution of β-catenin (Fig. 3F). Here, CNOT12 is linked to esophageal squamous cell carcinoma.